Impact of the COVID-19 pandemic on HPV vaccination coverage in the general population and in PLWHs.
Eur Rev Med Pharmacol Sci
; 26(19): 7285-7289, 2022 Oct.
Article
in English
| MEDLINE | ID: covidwho-2081432
ABSTRACT
OBJECTIVE:
On March 11, 2020, the World Health Organization (WHO) has declared the novel coronavirus (COVID-19) outbreak as a global pandemic. COVID-19 pandemic has impacted health services, including immunization programs, with a consequent reduction in vaccination coverage in those categories for which the prevention of vaccine-preventable diseases is strongly recommended. SUBJECTS ANDMETHODS:
We conducted a retrospective cross-sectional study on the general population and on PLWHs, comparing anti-human papillomavirus (HPV) vaccination coverage data in 2019, before COVID-19 pandemic, and the 2020 data, after the announcement of the pandemic state and the lockdown and the implementation of restrictive measures to contain the contagion.RESULTS:
Compared to 2019, 2020 data show a 42% reduction in HPV vaccine coverage in the general population and 36% in PLWHs. The greatest reduction in anti-HPV vaccination coverage occurred during periods of greatest restriction and mainly concerned the general population.CONCLUSIONS:
The prevention of vaccine-preventable diseases remains essential. Above all, it is essential to increase and recover the anti-HPV vaccine coverage, in consideration of the data that show its preventive oncological efficacy.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Papillomavirus Infections
/
Papillomavirus Vaccines
/
Vaccine-Preventable Diseases
/
COVID-19
Type of study:
Experimental Studies
/
Observational study
/
Randomized controlled trials
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Eur Rev Med Pharmacol Sci
Journal subject:
Pharmacology
/
Toxicology
Year:
2022
Document Type:
Article
Affiliation country:
Eurrev_202210_29922
Similar
MEDLINE
...
LILACS
LIS